Work

ABCL-351 LOTIS-5, an Ongoing, Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Year: 2024

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)01518-0

Authors: Michal T. Kwiatek, Carmelo Carlo-Stella, Andrzej Urban, Andrew Niewiarowski, Luqiang Wang, Mary Laughlin, Mehdi Hamadani

Institutions: Humanitas University, IRCCS Humanitas Research Hospital, Adc Therapeutics (Switzerland), Medical College of Wisconsin

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401876250

FWCI: 0.304

Cites:

Cited by: 1

Related to: 10